Clinical effect not specified
Source: DDInter
Tetracycline · Antibiotic
Also known as Demeclocycline hydrochloride, Demethylchlortetracycline, Ledermycin
Demeclocycline is a tetracycline antimicrobial drug. As an antibiotic, it is presumed to inhibit bacterial protein synthesis, although the specific mechanism for demeclocycline is not detailed in the excerpts. It also attenuates the antidiuretic effects of vasopressin, likely by decreasing the accumulation and action of cyclic AMP, though the full mechanism for this interference is not completely determined.
Should not be given to pregnant women. Effects on skeletal development have been documented in the first trimester in animal studies. Administration during the second or third trimester may cause discoloration of the child’s teeth, and maternal hepatotoxicity has been reported with large parenteral doses.
Should not be given to women who are breast-feeding (although absorption and therefore discoloration of teeth in the infant is probably usually prevented by chelation with calcium in milk).
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Reduced effectiveness of desmopressin.
Not explicitly stated, but implies monitoring for therapeutic effect.
Source: DDInter
3 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Harrison 22e, Katzung, BNF·Verified: 2026-05-13 · House clinical team